Stock of the day: CSL Limited
CSL emerges as a standout performer, reporting a 20% profit increase driven by its blood plasma division. Discover how CSL’s strategic acquisitions and robust growth trajectory make it a compelling choice for investors.
[AI generated]
This video was created on 13 August for IG audiences by ausbiz.
Stock of the day: CSL Limited (ASX: CSL)
CSL outperforms market expectations
In today’s financial spotlight, CSL emerges as a standout performer despite broader market concerns. The global healthcare giant reported a 20% increase in full-year profit, driven by robust growth in its blood plasma division. CSL's profit surged to $2.64 billion, with the company projecting further earnings growth of 10-13% for the 2025 financial year.
Shareholder returns and market reaction
Investors are set to receive a substantial final dividend of $0.45 per share, pushing the total annual dividend to $2.64 - a 12% increase. The market responded positively to these results, with CSL’s stock price climbing by 4%. This rebound is notable as CSL’s share price had previously dipped to $230 over the last year but has since recovered to around $300.
Strategic acquisitions and outlook
Despite recent challenges, including high costs and the integration of a significant Swiss acquisition, CSL anticipates continued margin improvements. The company's strategic expansion into the containerised freight market and its existing robust infrastructure in Queensland and New South Wales underscore its growth trajectory.
CSL’s resilience and strategic acquisitions underscore its capability to sustain growth, making it a compelling choice for investors looking for stability and growth in the healthcare sector.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.
